N-Boc Palbociclib-d4
N-Boc Palbociclib-d4 is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Palbociclib. The product is supplied by Clearsynth under CAT No. CS-T-103846. Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Product Specifications
Overview
Isotope labelled N-Boc Palbociclib is a protected Palbociclib (P139900), (also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.
Synonyms
N-Boc Palbociclib-d4
Molecular Formula
C 29 H 33 D 4 N 7 O 4
Molecular Weight
551.67
Additionnal Information
N-Boc Palbociclib-d4 is supplied with detailed characterization data compliant with regulatory guideline. N-Boc Palbociclib-d4 can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Palbociclib.
Storage Conditions
Refer MSDS for complete information.
Applications Notes
Isotope labelled N-Boc Palbociclib is a protected Palbociclib (P139900), (also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.
HSN Code
38229010
Hazard Compound
Refer MSDS for complete information.
More Discoveries
Explore Other Products
Browse additional items from our catalog
UCB49930-01 100 mg
4- (morpholinomethyl) -3- (trifluoromethyl) aniline
Sign In for Pricing
View Details UCB49930-02 1 g
4- (morpholinomethyl) -3- (trifluoromethyl) aniline
Sign In for Pricing
View Details 